Rock Springs Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.5M | Sell |
140,296
-26,402
| -16% | -$7.99M | 2.65% | 9 |
|
|
2025
Q1 | $55.2M | Sell |
166,698
-98,514
| -37% | -$32.6M | 3.16% | 4 |
|
|
2024
Q4 | $81.8M | Buy |
265,212
+2,150
| +0.8% | +$663K | 3.12% | 8 |
|
|
2024
Q3 | $55.8M | Buy |
263,062
+17,563
| +7% | +$3.73M | 1.82% | 15 |
|
|
2024
Q2 | $68.8M | Sell |
245,499
-40,432
| -14% | -$11.3M | 2.07% | 10 |
|
|
2024
Q1 | $76.4M | Buy |
285,931
+87,762
| +44% | +$23.4M | 1.94% | 16 |
|
|
2023
Q4 | $45.9M | Buy |
198,169
+1,800
| +0.9% | +$416K | 1.13% | 30 |
|
|
2023
Q3 | $28.7M | Sell |
196,369
-2,849
| -1% | -$416K | 0.77% | 44 |
|
|
2023
Q2 | $46M | Sell |
199,218
-148,903
| -43% | -$34.4M | 1.09% | 31 |
|
|
2023
Q1 | $84.3M | Hold |
348,121
| – | – | 2.01% | 14 |
|
|
2022
Q4 | $101M | Buy |
348,121
+30,636
| +10% | +$8.89M | 2.43% | 11 |
|
|
2022
Q3 | $20.6M | Hold |
317,485
| – | – | 0.53% | 54 |
|
|
2022
Q2 | $22.7M | Buy |
317,485
+43,985
| +16% | +$3.15M | 0.66% | 45 |
|
|
2022
Q1 | $26.8M | Buy |
273,500
+4,100
| +2% | +$402K | 0.68% | 48 |
|
|
2021
Q4 | $22.8M | Buy |
269,400
+6,900
| +3% | +$585K | 0.53% | 60 |
|
|
2021
Q3 | $20.9M | Hold |
262,500
| – | – | 0.44% | 71 |
|
|
2021
Q2 | $25.6M | Buy |
262,500
+4,000
| +2% | +$390K | 0.51% | 62 |
|
|
2021
Q1 | $30.2M | Buy |
258,500
+1,732
| +0.7% | +$203K | 0.66% | 51 |
|
|
2020
Q4 | $28.5M | Buy |
256,768
+2,500
| +1% | +$278K | 0.61% | 55 |
|
|
2020
Q3 | $30.2M | Hold |
254,268
| – | – | 0.77% | 43 |
|
|
2020
Q2 | $28.8M | Buy |
254,268
+4,268
| +2% | +$483K | 0.79% | 50 |
|
|
2020
Q1 | $16.7M | Sell |
250,000
-200
| -0.1% | -$13.4K | 0.69% | 52 |
|
|
2019
Q4 | $22.8M | Sell |
250,200
-22,200
| -8% | -$2.02M | 0.72% | 54 |
|
|
2019
Q3 | $23.5M | Buy |
272,400
+15,500
| +6% | +$1.34M | 0.94% | 38 |
|
|
2019
Q2 | $26.9M | Buy |
256,900
+1,650
| +0.6% | +$173K | 0.97% | 35 |
|
|
2019
Q1 | $32M | Buy |
255,250
+14,250
| +6% | +$1.78M | 1.23% | 22 |
|
|
2018
Q4 | $27.2M | Sell |
241,000
-101,000
| -30% | -$11.4M | 1.28% | 24 |
|
|
2018
Q3 | $73.2M | Sell |
342,000
-300
| -0.1% | -$64.2K | 2.65% | 6 |
|
|
2018
Q2 | $95.7M | Buy |
342,300
+16,800
| +5% | +$4.7M | 3.68% | 2 |
|
|
2018
Q1 | $38M | Sell |
325,500
-16,500
| -5% | -$1.93M | 1.62% | 13 |
|
|
2017
Q4 | $31.4M | Buy |
342,000
+67,000
| +24% | +$6.15M | 1.42% | 19 |
|
|
2017
Q3 | $12.4M | Sell |
275,000
-265,000
| -49% | -$11.9M | 0.57% | 56 |
|
|
2017
Q2 | $8.78M | Buy |
540,000
+315,000
| +140% | +$5.12M | 0.44% | 67 |
|
|
2017
Q1 | $3.47M | Buy |
225,000
+50,109
| +29% | +$772K | 0.2% | 105 |
|
|
2016
Q4 | $2.61M | Buy |
174,891
+111,891
| +178% | +$1.67M | 0.17% | 105 |
|
|
2016
Q3 | $799K | Buy |
+63,000
| New | +$799K | 0.05% | 133 |
|